Previous Close | 3.3000 |
Open | 3.3000 |
Bid | 1.8000 |
Ask | 2.2000 |
Strike | 260.00 |
Expire Date | 2024-10-18 |
Day's Range | 3.3000 - 3.3000 |
Contract Range | N/A |
Volume | |
Open Interest | 96 |
QIAGEN (QGEN) launches the new QIAseq Multimodal DNA/RNA Lib Kit, facilitating multiomic studies and advancing precision medicine.
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The commercialization of Teleflex's (TFX) UroLift in Japan has been a significant step toward making this therapy more broadly available to men suffering from BPH.